Molecure SA banner

Intrinsic Value

The intrinsic value of Molecure SA (MOC) under the Base Case is 3.02 PLN per share. Compared with the current market price of 5.9 PLN, the stock appears Overvalued by 49% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

MOC Intrinsic Value
zł3.02
Overvaluation 49%
Intrinsic Value
Price zł5.9
M

MOC is cheaper than usual. Still overvalued, but less so than on 84% of days in the past 5 years.

Monitor MOC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value zł2.42
Get notified when the price drops into your buy zone
Current Price zł5.9
Intrinsic Value zł3.02
Margin of Safety 20% zł2.42
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MOC

Fundamental Analysis

What Molecure Does

Pharmaceuticals Health Care

Molecure SA is a Polish biotechnology company that discovers and develops small-molecule medicines, mainly for diseases with few good treatment options. Its work centers on drug research in areas such as inflammation, fibrosis, and cancer, where it tries to identify new biological targets and turn them into drug candidates that can move into clinical testing.

Headquarters
Poland PL
Employees
106
IPO date
Apr 19, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Molecure SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one MOC stock?

The intrinsic value for Molecure SA (MOC) under the Base Case is 3.02 PLN.

Is MOC stock undervalued or overvalued?

Compared with the current market price of 5.9 PLN, the stock appears Overvalued by 49% .

Back to Top